Spero Therapeutics, Inc.SPRONASDAQ
Loading
Income Before Tax Over TimeExpanding
Percentile Rank60
Studio
Year-over-Year Change

Pre-tax earnings

Percentile
P60
Within normal range
vs 2Y Ago
-1.7x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$-43.55M+36.5%
2024$-68.57M-369.9%
2023$25.40M+154.7%
2022$-46.41M+48.3%
2021$-89.76M-14.7%
2020$-78.28M-28.5%
2019$-60.92M-46.2%
2018$-41.66M+9.6%
2017$-46.10M-41.2%
2016$-32.64M-